NASDAQ:QTRX - Get Free Report ) hit a new 52-week low on Wednesday . The company traded as low as $14.26 and last traded at $16.32, with a volume of 152448 shares trading hands. The stock had previously closed at $17.36.
Get Quanterix alerts:
Sign Up
Wall Street Analysts Forecast Growth Several brokerages recently issued reports on QTRX. Scotiabank increased their price objective on Quanterix from $30.00 to $32.00 and gave the stock a "sector outperform" rating in a research note on Monday, March 4th. Canaccord Genuity Group reduced their price target on shares of Quanterix from $32.00 to $25.00 and set a "buy" rating for the company in a research report on Monday, April 29th. Five research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, Quanterix currently has a consensus rating of "Buy" and a consensus target price of $30.60.
Get Our Latest Report on Quanterix
Quanterix Price Performance The business has a 50 day simple moving average of $21.51 and a 200 day simple moving average of $23.14. The stock has a market cap of $631.51 million, a PE ratio of -18.53 and a beta of 1.41.
Quanterix (NASDAQ:QTRX - Get Free Report ) last announced its quarterly earnings results on Thursday, February 29th. The company reported ($0.33) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.28) by ($0.05). The firm had revenue of $31.55 million for the quarter, compared to analyst estimates of $27.92 million. Quanterix had a negative net margin of 26.42% and a negative return on equity of 9.15%. As a group, sell-side analysts forecast that Quanterix Co. will post -1.04 earnings per share for the current fiscal year.
Insider Transactions at Quanterix In related news, Director Laurie J. Olson sold 1,500 shares of Quanterix stock in a transaction on Wednesday, February 14th. The shares were sold at an average price of $24.35, for a total value of $36,525.00. Following the completion of the sale, the director now owns 15,238 shares of the company's stock, valued at approximately $371,045.30. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website . 6.90% of the stock is currently owned by company insiders.
Institutional Inflows and Outflows A number of institutional investors have recently made changes to their positions in QTRX. Robeco Institutional Asset Management B.V. acquired a new position in Quanterix during the third quarter valued at approximately $67,000. AJOVista LLC bought a new position in Quanterix in the 4th quarter worth $81,000. DekaBank Deutsche Girozentrale acquired a new position in Quanterix during the 3rd quarter worth $125,000. Picton Mahoney Asset Management bought a new stake in Quanterix during the fourth quarter valued at about $139,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank grew its position in shares of Quanterix by 56.5% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 7,683 shares of the company's stock valued at $209,000 after purchasing an additional 2,775 shares during the last quarter. 86.48% of the stock is owned by institutional investors.
About Quanterix (
Get Free Report )
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.
Further Reading Before you consider Quanterix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Quanterix wasn't on the list.
While Quanterix currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report
